BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26559025)

  • 1. Decrease of ZEB1 expression inhibits the B16F10 cancer stem-like properties.
    Zhao F; He X; Wang Y; Shi F; Wu D; Pan M; Li M; Wu S; Wang X; Dou J
    Biosci Trends; 2015 Oct; 9(5):325-34. PubMed ID: 26559025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs.
    Dou J; He X; Liu Y; Wang Y; Zhao F; Wang X; Chen D; Shi F; Wang J
    Cell Biol Int; 2014 Apr; 38(4):452-61. PubMed ID: 24339410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
    Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
    Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis.
    Wang X; He X; Zhao F; Wang J; Zhang H; Shi F; Zhang Y; Cai K; Dou J
    J Transl Med; 2014 Mar; 12():68. PubMed ID: 24625224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
    Chen D; Wang J; Zhang Y; Chen J; Yang C; Cao W; Zhang H; Liu Y; Dou J
    Int J Gynecol Cancer; 2013 Oct; 23(8):1357-66. PubMed ID: 24257549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir.
    Wang X; Zhao F; Shi F; He X; Pan M; Wu D; Li M; Zhang Y; Dou J
    Biomed Pharmacother; 2016 May; 80():136-144. PubMed ID: 27133050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB1 promotes epithelial-mesenchymal transition in cervical cancer metastasis.
    Ran J; Lin DL; Wu RF; Chen QH; Huang HP; Qiu NX; Quan S
    Fertil Steril; 2015 Jun; 103(6):1606-14.e1-2. PubMed ID: 25963537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
    Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N
    Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
    Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced DAPK1 Expression Promotes Stem Cell-Like Characteristics of Prostate Cancer Cells by Activating ZEB1 via Hippo/YAP Signaling Pathway.
    Nong S; Wei Z; Wang Z; Ma L; Guan Y; Ni J
    Stem Cells Dev; 2021 Sep; 30(18):934-945. PubMed ID: 34289746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study of the inhibitory effect and mechanism of B16F10-ESAT-6-gpi/IL-21 vaccine on the pulmonary metastasis in mouse models of melanoma].
    He X; Shi W; Zhao F; Wang J; Xu X; Tan Q; Sun Y; Chen D; Dou J
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):245-9. PubMed ID: 24989908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.
    Tsai SC; Lin CC; Shih TC; Tseng RJ; Yu MC; Lin YJ; Hsieh SY
    Mol Carcinog; 2017 Sep; 56(9):2035-2047. PubMed ID: 28383782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.
    Li Y; Wang L; Pappan L; Galliher-Beckley A; Shi J
    Mol Cancer; 2012 Nov; 11():87. PubMed ID: 23174018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.
    Nurwidya F; Takahashi F; Winardi W; Tajima K; Mitsuishi Y; Murakami A; Kobayashi I; Nara T; Hashimoto M; Kato M; Hidayat M; Suina K; Hayakawa D; Asao T; Ko R; Shukuya T; Yae T; Shimada N; Yoshioka Y; Sasaki S; Takahashi K
    Thorac Cancer; 2021 May; 12(10):1536-1548. PubMed ID: 33764690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.
    Zhao F; Zhang R; Wang J; Wu D; Pan M; Li M; Guo M; Dou J
    Int Immunopharmacol; 2017 Nov; 52():238-244. PubMed ID: 28950176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Knock-down of ZEB1 inhibits the proliferation, invasion and migration of gastric cancer cells].
    Chen D; Chu Y; Zheng Q; Xu Z; Zhou P; Li S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Aug; 33(8):1073-1078. PubMed ID: 28871949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.
    Siebzehnrubl FA; Silver DJ; Tugertimur B; Deleyrolle LP; Siebzehnrubl D; Sarkisian MR; Devers KG; Yachnis AT; Kupper MD; Neal D; Nabilsi NH; Kladde MP; Suslov O; Brabletz S; Brabletz T; Reynolds BA; Steindler DA
    EMBO Mol Med; 2013 Aug; 5(8):1196-212. PubMed ID: 23818228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.